C. Valenzuela (Alcobendas (Madrid), Spain), P. Spagnolo (Liestal, Switzerland)
Late Breaking Abstract - Air pollution and IPF acute exacerbation I. Tomos (Athens, Alimos, Greece)
| |
Diffuse pulmonary ossification in Idiopathic Pulmonary Fibrosis: Forli 10-year experience N. Muhammad (Bandar Baru Bangi, Selangor, Malaysia)
| |
Hospital readmission increases short and long – term mortality in patients with interstitial lung disease after acute respiratory worsening. S. Barril Farre (BARCELONA, Spain)
| |
Mosaic attenuation in chronic hypersensitivity pneumonitis is not a synonym of air trapping (AT) O. Dias (Sao Paulo/Sp, Brazil)
| |
Smoking and interstitial lung diseases(ILDs). E. Puscinska (Warszawa, Poland)
| |
Post-transplant morbidity and mortality in patients with pulmonary fibrosis and telomeric shortening M. Garcia Moyano (Barakaldo, Spain)
| |
Pulmonary hypertension by right heart catheterization in patients with interstitial lung diease N. Mogulkoc (IZMIR, Turkey)
| |
Effect of Nintedanib in a rat model of lung fibrosis induced by single or double bleomycin administration M. Pittelli (PARMA (PR), Italy)
| |
The impact of dyspnoea and strategies used by lung fibrosis patients to relieve breathlessness. N. Cassidy (Dublin 5, Ireland)
| |
Portable oxygen concentrator vs oxygen cylinder during walking in ILD: a randomised crossover trial Y. Khor (Melbourne, VIC, Australia)
| |
AmbOx trial: does ambulatory oxygen improve quality of life in patients with fibrotic interstitial lung disease? E. Renzoni (London, United Kingdom)
| |
Installation of a Multidisciplinary team (MDT) review board for children´s interstitial lung disease (ILD) E. Seidl (Munich, Germany)
| |
High-resolution CT (HRCT) reflects disease progression in patients with idiopathic pulmonary fibrosis (IPF) E. Balestro (Padova, PD, Italy)
| |
IL-9 and IL-9 receptor (IL-9r) expression in BALF lymphocytes in ILD patients: preliminary results. F. Bonella (Dusseldorf, Germany)
| |
Technology of choosing a place of lung biopsy for disseminated lung interstitial lesions on the base of 3D-modeling E. Filatova (Ekaterinburg, Sverdlovsk Oblast, Russian Federation)
| |
Effect of 24-month Pirfenidone treatment on functional decline in Idiopathic Pulmonary Fibrosis (IPF) patients with rapid and slow disease progression D. Biondini (Udine, UD, Italy)
| |